XML 46 R40.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock Based Compensation - Summary of RSU Activity (Detail) - RSUs [Member]
6 Months Ended
Jun. 30, 2024
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Unvested Shares, Beginning Balance | shares 5,619,438
Granted | shares 4,238,499
Vested and issued | shares (1,213,777)
Cancelled | shares (1,029,296)
Unvested Shares, Ending Balance | shares 7,614,864
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 5.9
Weighted Average Grant Date Fair Value, Granted | $ / shares 1.89
Weighted Average Grant Date Fair Value, Vested and issued | $ / shares 6.54
Weighted Average Grant Date Fair Value, Cancelled | $ / shares 5.6
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 3.6
Service Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Unvested Shares, Beginning Balance | shares 5,102,268
Granted | shares 4,238,499
Vested and issued | shares (1,213,777)
Cancelled | shares (1,012,110)
Unvested Shares, Ending Balance | shares 7,114,880
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 6.04
Weighted Average Grant Date Fair Value, Granted | $ / shares 1.89
Weighted Average Grant Date Fair Value, Vested and issued | $ / shares 6.54
Weighted Average Grant Date Fair Value, Cancelled | $ / shares 5.39
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 3.57
Performance Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Unvested Shares, Beginning Balance | shares 517,170
Cancelled | shares (17,186)
Unvested Shares, Ending Balance | shares 499,984
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 4.54
Weighted Average Grant Date Fair Value, Cancelled | $ / shares 18.33
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 4.06